<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The influence of dietary composition on the <z:e sem="disease" ids="C0268306" disease_type="Disease or Syndrome" abbrv="">unconjugated hyperbilirubinaemia</z:e> of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> was studied in 29 patients </plain></SENT>
<SENT sid="1" pm="."><plain>After a period on a <z:mpath ids='MPATH_458'>normal</z:mpath> diet (10 MJ) an intravenous infusion of 40% <z:chebi fb="105" ids="17234">glucose</z:chebi> (8-4 MJ) together with a 1-6 MJ oral diet for two days resulted in an increment in plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentration of 127 +/- 18% (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) above the basal level </plain></SENT>
<SENT sid="2" pm="."><plain>Both the administration of intravenous Intralipid 20% and the return to a <z:mpath ids='MPATH_458'>normal</z:mpath> diet caused a prompt reversal of this <z:chebi fb="105" ids="17234">glucose</z:chebi> effect </plain></SENT>
<SENT sid="3" pm="."><plain>An increment of 135 +/- 10% in plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentration was obtained when a standard "fasting" diet (1-6 MJ) was given for two days </plain></SENT>
<SENT sid="4" pm="."><plain>When the <z:chebi fb="23" ids="18059">lipid</z:chebi> content of this "fasting" diet was increased from 33% to 85%, the rise in plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> was only 49 +/- 19% </plain></SENT>
<SENT sid="5" pm="."><plain>A 10 MJ oral diet for three days, which contained most of its energy content as carbohydrate and only 0-6% as <z:chebi fb="23" ids="18059">lipid</z:chebi>, produced a 76 +/- 12% increase in plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentration </plain></SENT>
<SENT sid="6" pm="."><plain>When the <z:chebi fb="23" ids="18059">lipid</z:chebi> content of the diet was increased to 9% of the energy intake no significant change from the basal level was observed </plain></SENT>
<SENT sid="7" pm="."><plain>These findings support the hypothesis that the <z:e sem="disease" ids="C0020433" disease_type="Disease or Syndrome" abbrv="">hyperbilirubinaemia</z:e> associated with both carbohydrate feeding and fasting is attributable, at least in part, to <z:chebi fb="23" ids="18059">lipid</z:chebi> withdrawal </plain></SENT>
<SENT sid="8" pm="."><plain>Although a restricted dietary intake or the parenteral administration of <z:chebi fb="23" ids="18059">lipid</z:chebi>-free solutions has a marked effect on the <z:e sem="disease" ids="C0020433" disease_type="Disease or Syndrome" abbrv="">hyperbilirubinaemia</z:e> of patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, <z:mpath ids='MPATH_458'>normal</z:mpath> daily variation in dietary composition is unlikely to cause a significant change </plain></SENT>
<SENT sid="9" pm="."><plain>The influence of different feeding regimes on <z:e sem="disease" ids="C0857007" disease_type="Disease or Syndrome" abbrv="">neonatal hyperbilirubinaemia</z:e> requires investigation </plain></SENT>
</text></document>